Clinical Trial Update: Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Photodynamic Therapy to Eplerenone for chronic central serous chorioretinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Photodynamic Therapy
• eplerenone (eplerenone)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Chronic Central Serous Chorioretinopathy | Phase 4 | Status: UNKNOWN